Japan· JP-8112001B1013
アヘン
A opium product containing アヘン, registered in Japan, on the national reimbursement list. The same ATC class is registered in 11 of our 19 countries.
Checked against MHLW / PMDA (Japan) on
Informational only — not a medical device.
Where it is registered
Opium is registered in 11 of 19 countries.
Countries holding a registration under ATC A07DA02 (opium), each read from that country’s own register.
- This record: Japan, from MHLW / PMDA (Japan)
- 6 of them publish a price we can compare per daily dose
Opium · ATC A07DA02
11 / 19 countries
- Belgiumprice
- Czechiaprice
- Denmark
- Finlandprice
- Icelandprice
- Ireland
- Japan
- Netherlands
- Norwayprice
- Switzerlandprice
- United Kingdom
The record
At a glance
MHLW / PMDA (Japan)- Active substance
- アヘン
- Manufacturer
- —
- Country
- Japan (JP)
- ATC code
- A07DA02
- ATC class
- Opium
- Defined daily dose
- 1 g, O
- Reimbursed
- Yes
- Source register
- MHLW / PMDA (Japan)
- Last checked
- September 25, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
408 interactions on record for opium.
Graded by severity as the source publishes them — 23 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Opium · interactions on record
408 records
- 23 severe
- 385 moderate
Most severe, free to view
- AlvimopanA06AH02severe
- LinezolidJ01XX08severe
- ProcarbazineL01XB01severe
- CimetidineA02BA01moderate
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Opium in 9 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- BelgiumOpium Boiron 15CHBoiron
- United KingdomCamphorated opium tinctureA A H Pharmaceuticals Ltd
- FinlandDropizolPharmanovia A/S
- GermanyDropizolPharmanovia A/S
- SwedenDropizol 10 mg/ml Orala droppar, lösningPharmanovia A/S
- FranceDROPIZAL 10 mg/mL, solution buvable en gouttesPHARMANOVIA (DANEMARK)
- IrelandDropizol 10 mg/ml Oral Drops SolutionAtnahs Pharma Nordics A/S
- IcelandDropizolPharmanovia A/S
Authorised across Europe · EMA
The same active substance is authorised in 16 EEA countries. Names it is sold under:
- Austria · Dropizol
- Czechia · Dropizol
- Germany · Dropizol, Dropizole
- Denmark · Dropizol
- Spain · Dropizol
- Finland · Dropizol
- France · Dropizal
- United Kingdom (Northern Ireland) · Dropizol
- Hungary · Dropizol
- Ireland · Dropizol
- Iceland · Dropizol
- Netherlands · Dropizol
- Norway · Dropizol
- Portugal · Dropizale
- Sweden · Dropizol
- Slovakia · Dropizol
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of MHLW / PMDA (Japan). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/414d5aa5-d595-44fb-8512-28d7a1d74ed4 GET /v1/drugs/414d5aa5-d595-44fb-8512-28d7a1d74ed4?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"spec": "１０％１ｇ",
"marks": "局 麻",
"source": "mhlw",
"remarks": null,
"yj_code": "8112001B1013",
"category": "内用薬",
"price_yen": null,
"generic_name": "アヘン",
"product_name_jp": null,
"therapeutic_class": "8112",
"transitional_expiry": null
}See everything about opium.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.